K S Stote1, R P Tracy2, P R Taylor3, D J Baer1. 1. Beltsville Human Nutrition Research Center, US Department of Agriculture, Agriculture Research Service, Beltsville, MD, USA. 2. University of Vermont College of Medicine, Burlington, VT, USA. 3. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Abstract
BACKGROUND/ OBJECTIVES: Inflammation and hemostasis contribute to the etiology of cardiovascular disease. We previously demonstrated that moderate alcohol consumption (1-2 drinks/day) may decrease risk for cardiovascular disease because of an improved lipid profile. In addition to these beneficial changes, the alcohol-mediated reduction in risk may be through its effect on inflammation and hemostasis. The objective of the study was to evaluate the effect of moderate alcohol consumption on biomarkers of inflammation and hemostasis in postmenopausal women. SUBJECTS/ METHODS: As part of a controlled diet study, 53 postmenopausal women each consumed aweight-maintaining diet plus 0, 15 and 30 g/day of alcohol for 8 weeks, in a randomized crossover design. The controlled diet contained 15%, 53% and 32% of energy from protein, carbohydrate and fat, respectively. RESULTS:Soluble intercellular adhesion molecule-1 decreased by 5% (P<0.05) with consumption of both 15 and 30 g of alcohol. Fibrinogen concentrations decreased by 4% and 6% (P<0.05) after consumption of 15 and 30 g alcohol, respectively. Fibrin D-dimer decreased by 24% (P<0.05) after consumption of 30 g of alcohol. Plasminogen activator inhibitor-1 (PAI-1) concentrations were increased 27 and 54% (P<0.05) after consumption of 15 and 30 g of alcohol. Plasma high-sensitivity C-reactive protein, interleukin-6 and factor VII coagulant activity did not change with alcohol consumption. CONCLUSIONS: These data suggest that moderate alcohol consumption may have beneficial effects on inflammation and hemostasis in postmenopausal women, and this may be somewhat mitigated by an increase in PAI-1.
RCT Entities:
BACKGROUND/ OBJECTIVES:Inflammation and hemostasis contribute to the etiology of cardiovascular disease. We previously demonstrated that moderate alcohol consumption (1-2 drinks/day) may decrease risk for cardiovascular disease because of an improved lipid profile. In addition to these beneficial changes, the alcohol-mediated reduction in risk may be through its effect on inflammation and hemostasis. The objective of the study was to evaluate the effect of moderate alcohol consumption on biomarkers of inflammation and hemostasis in postmenopausal women. SUBJECTS/ METHODS: As part of a controlled diet study, 53 postmenopausal women each consumed a weight-maintaining diet plus 0, 15 and 30 g/day of alcohol for 8 weeks, in a randomized crossover design. The controlled diet contained 15%, 53% and 32% of energy from protein, carbohydrate and fat, respectively. RESULTS: Soluble intercellular adhesion molecule-1 decreased by 5% (P<0.05) with consumption of both 15 and 30 g of alcohol. Fibrinogen concentrations decreased by 4% and 6% (P<0.05) after consumption of 15 and 30 g alcohol, respectively. Fibrin D-dimer decreased by 24% (P<0.05) after consumption of 30 g of alcohol. Plasminogen activator inhibitor-1 (PAI-1) concentrations were increased 27 and 54% (P<0.05) after consumption of 15 and 30 g of alcohol. Plasma high-sensitivity C-reactive protein, interleukin-6 and factor VII coagulant activity did not change with alcohol consumption. CONCLUSIONS: These data suggest that moderate alcohol consumption may have beneficial effects on inflammation and hemostasis in postmenopausal women, and this may be somewhat mitigated by an increase in PAI-1.
Authors: David J Baer; Joseph T Judd; Beverly A Clevidence; Richard A Muesing; William S Campbell; Ellen D Brown; Philip R Taylor Journal: Am J Clin Nutr Date: 2002-03 Impact factor: 7.045
Authors: G Chiva-Blanch; E Magraner; X Condines; P Valderas-Martínez; I Roth; S Arranz; R Casas; M Navarro; A Hervas; A Sisó; M Martínez-Huélamo; A Vallverdú-Queralt; P Quifer-Rada; R M Lamuela-Raventos; R Estruch Journal: Nutr Metab Cardiovasc Dis Date: 2014-08-02 Impact factor: 4.222
Authors: Edmund A Bermudez; Nader Rifai; Julie Buring; JoAnn E Manson; Paul M Ridker Journal: Arterioscler Thromb Vasc Biol Date: 2002-10-01 Impact factor: 8.311
Authors: Stefano Volpato; Marco Pahor; Luigi Ferrucci; Eleanor M Simonsick; Jack M Guralnik; Stephen B Kritchevsky; Renato Fellin; Tamara B Harris Journal: Circulation Date: 2004-02-10 Impact factor: 29.690
Authors: Johannes de Munter; Dmitrii Pavlov; Anna Gorlova; Michael Sicker; Andrey Proshin; Allan V Kalueff; Andrey Svistunov; Daniel Kiselev; Andrey Nedorubov; Sergey Morozov; Aleksei Umriukhin; Klaus-Peter Lesch; Tatyana Strekalova; Careen A Schroeter Journal: Front Nutr Date: 2021-04-15
Authors: Olesia Schapovalova; Anna Gorlova; Johannes de Munter; Elisaveta Sheveleva; Mikhail Eropkin; Nikita Gorbunov; Michail Sicker; Aleksei Umriukhin; Sergiy Lyubchyk; Klaus-Peter Lesch; Tatyana Strekalova; Careen A Schroeter Journal: Front Med (Lausanne) Date: 2022-08-22